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Inhibition of T Lymphocyte Mitogenesis
by 1,25-Dihydroxyvitamin D3 (Calcitriol)
William F. C. Rigby, Terryl Stacy, and Michael W. Fanger
Departments of Microbiology and Medicine, Dartmouth Medical
School, Hanover, NewHampshire 03756
Abstract. Recent studies have suggested that
vitamin D may have other important biologic activities
in addition to its well-characterized role in the mainte-
nance of calcium homeostasis. Discovery of cytosolic
receptors for vitamin D in human peripheral blood
monocytes and lectin-stimulated lymphocytes prompted
us to study the effects of 1,25-dihydroxyvitamin D3
(calcitriol), the most biologically active metabolite of
vitamin D, upon phytohemagglutinin (PHA)-induced
lymphocyte blast transformation. We have found that
calcitriol is a potent inhibitor of PHA-induced lympho-
cyte proliferation, achieving 70% inhibition of tritiated
thymidine incorporation after 72 h in culture. Further-
more, calcitriol suppressed interleukin-2 (IL-2) produc-
tion by PHA-stimulated peripheral blood mononuclear
cells in a concentration-dependent fashion. Lastly, the
suppressive effect of calcitriol on cellular proliferation
was partially reversed by the addition of saturating
amounts of purified IL-2. Weconclude that calcitriol is
a potent inhibitor of PHA-induced lymphocyte blast
transformation and that this effect is mediated, in part,
through suppression of IL-2 production. Thus, calcitriol
appears to possess immunoregulatory properties that
have been unappreciated heretofore.
Introduction
The role of vitamin D as a steroid hormone involved in
calcium homeostasis has been well defined in recent years (1).
The traditional target tissues for vitamin D action (intestine,
bone, and kidney) possess specific high-affinity cytosolic recep-
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tors for vitamin D and its metabolites (1). The discovery of
receptors for vitamin D in cells and cell lines derived from
tissues not clearly associated with calcium homeostasis (1) has
prompted reevaluation of the scope of the biologic role of
vitamin D.
The most biologically active form of vitamin D, 1,25-
dihydroxyvitamin D3 (calcitriol), has been demonstrated to
induce differentiation of both human and murine myeloid
leukemia cell lines and to prolong survival of mice injected
with a murine leukemia cell line (2-4). In addition, calcitriol
has been demonstrated to inhibit growth and induce differen-
tiation of the U937 monoblast cell line (5) derived from a
patient with histiocytic lymphoma (6). More recently, receptors
for vitamin D have been found in monocytes and in lympho-
cytes activated in vitro by either mitogenic lectin or Epstein-
Barr virus (7, 8).
The demonstration of vitamin D receptors in cells of
lymphoid origin prompted us to examine the effects of calcitriol
on lectin-induced lymphocyte blast transformation. Calcitriol
was found to be a potent inhibitor of phytohemagglutinin
(PHA)'-induced cellular proliferation as measured by tritiated
thymidine ([3H]TdR) incorporation at concentrations as low
as 10-1 M. Since proliferation of T lymphocytes in response
to either antigen or lectin has been shown to be mediated by
interleukin-2 (IL-2) (9, 10), the effects of calcitriol on IL-2
production by PHA-stimulated lymphocytes was examined.
Calcitriol inhibited IL-2 production with a concentration de-
pendence that approximated that found in the cellular prolif-
eration studies. The addition of saturating amounts of purified
exogenous IL-2 reversed the inhibition of proliferation induced
by calcitriol. Thus, calcitriol is a potent inhibitor of lectin-
stimulated lymphocyte blast transformation, at least in part as
a result of its suppression of IL-2 production.
Methods
Vitamin D compounds. Preservative free 1,25-dihydroxycholecalciferol
(calcitriol) and 25-hydroxycholecalciferol (25-OH-D3) were the generous
1. Abbreviations used in this paper: 25-OH-D3, 25-hydroxycholecalci-
ferol; CTLL, cloned murine IL-2-dependent T lymphocyte line; IL-2,
interleukin-2; PBM, peripheral blood mononuclear cells; PHA, phy-
tohemagglutinin; TdR, thymidine.
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gifts of Dr. Milan Uskokovic (Hoffman-La Roche, Inc., Nutley, NJ)
and Dr. Rodney Carlson (Upjohn Co., Kalamazoo, MI), respectively.
Vitamin D3 was purchased from Sigma Chemical Co. (St. Louis, MO).
All compounds were dissolved in 95% sterile ethanol and stored in
glass vials at -20'C.
Cell cultures. Human peripheral blood mononuclear (PBM) cells
isolated by Ficoll-Hypaque discontinuous gradient centrifugation were
cultured at 1 X 106 cells/ml in RPMI 1640 medium (KC Biologicals,
Lenexa, KS) supplemented with 10% heat-inactivated (560C, 30 min)
fetal bovine serum (Sterile Systems, Inc., Logan, UT) and 50 Mg/ml
gentamicin sulfate (U. S. Biochemical Corp., Cleveland, OH) at 370C
in a humidified atmosphere of 5% CO2 in air. Cells for proliferation
were stimulated with that concentration of PHA (Difco Laboratories,
Detroit, MI) which was found to cause maximal stimulation for 72 h.
Cell viability, as determined by acridine orange/ethidium bromide
staining (1 1), was equivalent between control and treated cultures after
72 h in culture.
Cells to be assayed for IL-2 production were cultured at 5 X 106
cells/ml in RPMI 1640 with 10% FBS in the presence of PHA (1.5
Mg/ml) (Wellcome Reagents Ltd., Beckenham, England) for 24 h. The
cell-free supernatant was harvested by centrifugation (1000 g; 15 min)
and stored at 4VC until assayed. The concentrations of these PHA
preparations (Difco Laboratories and Wellcome Reagents, Inc.) used
were found to give equivalent stimulation of PBMcells (106/ml) after
72-h culture, as measured by [3H]TdR (New England Nuclear, Boston,
MA) incorporation as described below.
Both sets of cultures were performed in the absence or presence of
varied concentrations of calcitriol or 25-OH-D3. Control cultures
contained equal volumes of ethanol, which never exceeded 0.1% in
control or treated cultures. Time course experiments were performed
with addition of calcitriol to cultures at various time points after PHA
stimulation, achieving a final concentration found to cause maximal
effect (lo-7 M).
Proliferation studies. After 72 h in culture, equal volumes (100 Ml)
of each sample were plated in quadruplicate into 96-well plates (Becton-
Dickinson Labware, Oxnard, CA). Cells were pulsed with 0.5 MCi of
[3H]TdR for 5 h at 370C and harvested onto glass fiber filters with a
Mash II Cell Harvester (Microbiological Associates, Walkersville, MD)
and counted by liquid scintillation. Data are expressed as: percent
inhibition = 1 - (cpm calcitriol culture/cpm control culture) X 100.
IL-2 biologic activity. IL-2 activity of cell-free supernatants was
determined as previously described (12) by the IL-2 concentration-
dependent stimulation of a cloned murine IL-2-dependent T lymphocyte
line (CTLL-2, subclone 15 G). CTLL proliferation, as monitored by
[3H]TdR (0.5 MCi) incorporation, was determined during the last 4 h
of a 24-h culture period in the presence of serial twofold dilutions of
a standard IL-2 preparation and the experimental sample. The dilutions
that yielded 50% of the maximal CTLL [3H]TdR incorporation were
determined by probit analysis; dilution values of the samples were
divided by that of the standard to give the concentration of IL-2 in
units per milliliter. The standard IL-2 preparation, which had been
arbitrarily assigned a value of 1 unit/ml, routinely yielded 50% of the
maximal [3H]TdR incorporation at a dilution of 1:25. CTLL prolifer-
ation was found to be unaffected by calcitriol over the range of
concentrations used ( _05-10-I2 M), so that any difference in CTLL
proliferation between control and treated (containing calcitriol) super-
natants was a function of IL-2 concentration. Stimulation by control
supernatants from each donor (measured as units IL-2 per milliliter)
were assigned a value of 100%, with treated supernatant activity
calculated as a percentage of that value.
Production and preparation of affinit-purified IL-2. Jurkat subclone
6.8 cells (10) were routinely harvested from the exponential phase of
cell growth (0.8-1.0 X 106 cells/ml), centrifuged (250 g; 10 min), placed
into serum-free Dulbecco's Modified Eagle's medium (Gibco Labora-
tories, Grand Island, NY), and cultured at 4.0 x 106 cells/ml for 14-
18 h in the presence of PHA(1.5 tg/ml) and phorbol myristate acetate
(50 ng/ml; Consolidated Midlands Corp., Brewster, NY). The cell-free
supernatant was harvested, filtered (0.45 Am), and stored at 40C. IL-2
was purified using an immunoaffinity column constructed with an
IgG2a monoclonal antibody to IL-2 (DMS-3), as previously described
(13). IL-2 activity was assayed as described above.
Results
Effect of vitamin D compounds on PHA-stimulated lymphocyte
proliferation. Calcitriol inhibited PHA-stimulated proliferation
of PBMcells in a dose-dependent fashion (Fig. 1). Demonstrable
inhibition was present at calcitriol concentrations as low as
10-12 Mwith maximal suppression (70-80%) usually apparent
at 10-7 M. Furthermore, the immediate biologic precursor of
calcitriol, 25-OH-D3, was without significant inhibitory effect
at concentrations below 10-6 M (Fig. 1). Vitamin D3 lacked
detectable antiproliferative effect at concentrations as high as
10-6 M(data not shown). As the relative inhibitory activity of
these vitamin D metabolites reflects the much greater affinity
of the vitamin D cytosolic receptor for calcitriol (14), it seems
likely that this inhibitory effect is receptor-mediated.
In an attempt to define whether there was a critical point
in the mitogenic stimulation of lymphocytes that was sensitive
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Figure 1. Inhibition of [3H]Tdr incorporation by PHA-stimulated
PBMcells by calcitriol. PBMcells from three donors were stimulated
with PHA for 72 h with an ethanol control, calcitriol (i, A, *), or 25-
OH-D3 (0, &, o) and pulsed for 5 h with [3H]TdR. Error bars
represent standard deviation of quadruplicate samples. Percentage
inhibition was calculated as: percent inhibition = 1 - (cpm treated
culture/cpm control culture) X 100.
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PBMcells (Fig. 2). Although there was individual variability,
if addition of calcitriol was delayed relative to PHAstimulation,
less inhibition resulted. In all cases, significant reduction of
calcitriol's inhibitory effect (measured 72 h after PHA stimu-
lation) was apparent when it was added 24 h after culture with
PHA. In some cases, the inhibition of proliferation was nearly
obviated by the addition of calcitriol after 48 h.
Effect of calcitriol on IL-2 production. Since IL-2 is essential
for the proliferation of lectin-stimulated T lymphocytes, studies
of calcitriol's effect on IL-2 production were conducted. The
production of IL-2 by PHA-stimulated lymphocytes was inhib-
ited by calcitriol in a linear, dose-dependent fashion (Fig. 3).
At a concentration of 10-' M, calcitriol suppressed IL-2 pro-
duction by 50%. Time course studies of IL-2 production
revealed that if addition of calcitriol were delayed for 12 h
following lectin stimulation, there was reduced inhibition (Fig.
4). These data show that calcitriol's effects on IL-2 production
and T cell proliferation are mediated at an early stage of
mitogenesis. Addition of calcitriol after substantial IL-2 pro-
duction has taken place, results in the attenuation of its
antiproliferative effect.
Lastly, to determine whether calcitriol had any inhibitory
effect on PHA-stimulated lymphocyte proliferation independent
of IL-2 production, we studied the effect of purified exogenous
IL-2 on calcitriol-treated cells (Table I). Supplementation of
PHA-stimulated PBMcells with saturating concentrations of
IL-2 reversed to varying degrees (29-66%) the inhibition of
proliferation induced by calcitriol (10'- M). In all of the six
donors studied, IL-2 addition did not restore proliferation to
control levels.
Discussion
In this paper, we report that at physiologic levels, calcitriol,
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Figure 2. Time course of calcitriol-mediated inhibition of [3H]Tdr
incorporation. PBMcells from four donors (A, o, o, *) were stimu-
lated with PHAat time 0, and calcitriol (10-7) was added to cultures
at various time points. Inhibition of proliferation was measured as
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Figure 3. Effect of calcitriol on IL-2 production. Supernatants of
PBMcells cultured in the absence or presence of calcitriol were
measured 24 h after PHA stimulation. The effect of calcitriol on IL-2
was calculated as a percentage of control for each donor. Each point
represents the mean and standard deviation with three donors.
inhibitor of PHA-induced lymphocyte proliferation. The degree
of inhibition of proliferation by calcitriol was unaffected by
PHA concentrations ranging from suboptimal levels up to
twice those required to achieve maximal stimulation (data not
shown). The immediate biologic precursor of calcitriol, 25-
OH-D3, was without comparable effect unless used at 10,000-
fold higher concentrations (10-6 M), and vitamin D3 had no
detectable effect. Since the cytoplasmic receptor for vitamin D
has a much greater affinity for calcitriol than for 25-OH-D3
(14), it seems likely that this suppression of lymphocyte
proliferation is receptor-mediated. The absence of antiprolifer-
ative activity with vitamin D3 provides further evidence of the
specificity of calcitriol's effects on T lymphocyte mitogenesis.
In addition, our finding that calcitriol decreased IL-2 production
and that its inhibition of proliferation could be at least partially
overcome by the addition of exogenous IL-2 suggested that
the antiproliferative effects of calcitriol may, in part, result
Figure 4. Time course
study of effects of calcitriol
on IL-2 production. PBM
cells from three donors (o,
C> 40 \ 4\ \ A a) were stimulated with
PHAat time 0, and calci-
triol (10-7 M) was added to
m 20 \ \ cultures at various time_ \ \\ points. Supernatants were
harvested at 24 h and IL-2
activity was measured. In-
0 6 12 18 hibition was calculated as
TIME (hours) described in Fig. 1.
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Table I. Ability of IL-2 to Overcome Inhibition of T Cell Mitogenesis by Calcitriol*
Donor (age [yr], sex) PHA PHA/calcitriol PHA/IL-2 PHA/IL-2/calcitriol
cpm
1 (39, F) 103,700±6,400 38,100±600 (37%) 101,500±8,900 (98%) 90,700±3,600 (88%)
2 (38, F) 142,200±3,200 45,900±2,100 (32%) 135,800±2,800 (96%) 120,800±4,100 (85%)
3 (21, F) 91,200±5,700 19,700±1,900 (22%) 95,500±6,200 (105%) 63,100±5,700 (69%)
4 (43, M) 111,000±6,800 49,300±3,500 (44%) 136,700±5,100 (123%) 83,900±4,800 (75%)
5 (23, M) 102,500±3,600 27,400±2,200 (27%) 92,200±3,900 (90%) 57,500±1,900 (56%)
6 (24, M) 119,000±2,500 22,300±2,000 (19%) 111,000±7,500 (93%) 100,900±4,100 (85%)
* [3H]Tdr incorporation mediated by 72-h PHA-stimulated PBMcells (106/ml) from six healthy donors. Cultures were conducted in the pres-
ence of either ethanol control, calcitriol (10-' M), or IL-2 (3 U/ml), or both calcitriol and IL-2. Numbers in parentheses denote percentage of
control (PHA alone) values.
from its suppression of IL-2 production. Studies using purified
IL-2 also indicate that calcitriol may inhibit mitogenesis through
other mechanisms in addition to inhibition of IL-2 production.
In contrast, the effect of glucocorticoids on T cell mitogenesis
can be overcome with exogenous IL-2 (9, 15). These studies
indicate that the steroid hormone, calcitriol, may be involved
in immunoregulation in addition to its well-recognized role in
calcium homeostasis.
Calcitriol's effects on proliferation and IL-2 production
appear to involve the early stages of mitogenesis, since there
is a significant loss of its suppressive properties when added to
cultures 12-18 h after lectin stimulation. Furthermore, it seems
unlikely that calcitriol inhibits IL-2 production through a
direct effect on the T cell. This is suggested by the finding that
calcitriol must be added to cultures within 12 h of PHA
stimulation to effect suppression of IL-2 production, whereas
specific receptors for vitamin D are not detectable in T
lymphocytes until 24 h after lectin stimulation (12). After
induction of vitamin D receptors, calcitriol could potentially
exert a direct antiproliferative effect on the T cell. One possible
mechanism might be through down-regulation of IL-2 receptor
expression (16). Such an effect could explain the failure of
exogenous IL-2 to fully restore proliferation to that of controls.
Another possibility consistent with this data is that calci-
triol's suppressive effects are mediated through monocytes,
which normally express cytosolic receptors specific for vitamin
D (7, 8). Calcitriol may, for example, decrease the capability
of the monocyte to produce interleukin I in response to PHA
stimulation, which would result in turn in decreased IL-2
production. In addition, calcitriol may induce the monocyte
to release a factor with direct inhibitory effects on lymphocyte
proliferation.
It has been recently reported that pulmonary alveolar
macrophages from patients with sarcoidosis have 1-hydroxylase
activity and can synthesize calcitriol from 25-OH-D3 (17). In
addition, peripheral blood lymphocytes from patients with
sarcoidosis have been shown to have depressed proliferative
responses to mitogens (18). Our demonstration of the immu-
nomodulatory effects of calcitriol on PHA-stimulated lympho-
cyte proliferation suggests a pathophysiologic mechanism which
could link these two observations. Moreover, it may be that,
under certain physiologic or other pathologic conditions, mac-
rophages may be induced to synthesize calcitriol from 25-OH-
D3. Thus, calcitriol may represent a product of macrophages
involved in the regulation of lymphocyte proliferation or
monocyte-macrophage differentiation and function as has been
reported in both human and murine myeloid cell lines (2-5).
The demonstration that calcitriol has immunoregulatory
properties including effects on lymphocytes similar to those of
glucocorticoids suggests that calcitriol, or other vitamin D
metabolites, may have potential utility in mediating immu-
nosuppression. The development of vitamin D analogs that
exert less effect on calcium homeostasis but retain their
inhibitory effects on lymphocyte proliferation might enable
their use as immunosuppressive agents. Such agents would
lack the morbidity of therapy (diabetes mellitus, osteopenia)
common to pharmacologic doses of glucocorticoids.
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